Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03272945
Other study ID # LCI
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 6, 2017
Est. completion date December 31, 2018

Study information

Verified date January 2019
Source Showa Inan General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Linked color imaging (LCI) was recently developed and uses a laser endoscopic system (Fujifilm Co, Tokyo, Japan) that acquires images by simultaneously using narrow-band short-wavelength light and white-light (WL) in an appropriate balance. LCI is a new image-enhancing technology that is intended to enhance slight color differences in the red region of the mucosa. The acquired color information is reallocated to differentiate colors that are similar to the mucosal color, resulting in improved performance in depicting blood vessels, and additional image processing that enhances color separation for red color permits clear visualization of red blood vessels and white pits. This modality may increase the detection rate of colorectal polyps by enhancing the visibility of colonic mucosal vessels. In addition, it has been reported that LCI increases the visibility of colorectal flat lesions and contributes to improvement of the detection rate for these lesions. The primary aim of the current study was to compare the detection rate of colorectal flat lesions of LCI cap-assisted colonoscopy with WL cap-assisted colonoscopy in prospective randomized trial. In addition, we prospectively compared LCI and WL with regard to the visibility of colorectal flat lesions found in this study.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date December 31, 2018
Est. primary completion date December 31, 2018
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria:

- We enrolled consecutive patients who were referred for colonoscopy to our hospital for diagnostic work up of colonic symptoms, surveillance of colorectal polyps, and colorectal cancer screening.

Exclusion Criteria:

- familial colorectal cancer syndrome including familial adenomatous polyposis and hereditary non-polyposis colorectal cancer syndrome, personal history of colorectal cancer or inflammatory bowel disease and those who had previous colonic resection.

Patients who were considered to be unsafe for polypectomy, including patients with bleeding tendency and those with severe comorbid illnesses, were excluded. Those in whom <90% of mucosa was seen due to mixture of semisolid and solid colonic contents were also excluded because of poor bowel preparation.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Linked-color imaging
Linked-color imaging colonoscopy

Locations

Country Name City State
Japan Showa Inan General hospital Komagane Nagano

Sponsors (1)

Lead Sponsor Collaborator
Showa Inan General Hospital

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Other The visibility of colorectal flat lesions Six endoscopists interpreted the images of CLI and WL. By using a previously reported visibility scale, we scored the visibility level on a scale of 1 to 4 and compared the two groups. 1 day
Primary Average prevalence of flat lesion /patient detected The total number of flat colorectal lesion/patient was defined. The average prevalence of flat lesion /patient detected was calculated. procedure
Secondary Adenoma detection rate Adenoma detection rate was defined as the proportion of patients with at least one adenoma found on colonoscopy. procedure
Secondary Polyp detection rate Polyp detection rate was defined as the proportion of patients with at least one polyp found on colonoscopy. procedure
See also
  Status Clinical Trial Phase
Recruiting NCT06062095 - Computer Aided Diagnosis (CADx) for Colorectal Polyps Resect-and-Discard Strategy N/A
Not yet recruiting NCT02688699 - Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract Phase 4
Active, not recruiting NCT03962868 - Endoscopic Submucosal Dissection (ESD) Versus Endoscopic Mucosal Resection (EMR) for Large Non Pedunculated Colonic Adenomas: a Randomized Comparative Trial N/A
Not yet recruiting NCT05776381 - The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp Phase 2
Recruiting NCT04157803 - Accuracy of aCETIC Acid to Predict Histopathology of Colonic Polyps N/A
Completed NCT03758872 - CUFF-assisted Colonoscopy vs Standard Colonoscopy
Recruiting NCT05870332 - Nationwide Study of Artificial Intelligence in Adenoma Detection for Colonoscopy
Completed NCT03690297 - Linked Color Imaging (LCI) for Colorectal Adenoma Detection N/A
Recruiting NCT03865537 - Cold Snare Endoscopic Mucosal Resection Trial N/A
Recruiting NCT04149184 - Computer-aided Detection Device in Standard Colonoscopy N/A
Recruiting NCT05099432 - The CARMA Technique Study N/A
Withdrawn NCT04778566 - Evaluating the Cologuard Test for Use in Lynch Syndrome
Withdrawn NCT01372696 - Endoscopic Characteristics of Colonic Tumours N/A
Recruiting NCT05322993 - Improving Polyp Detection Rate by Artificial Intelligence in Colonoscopy N/A
Completed NCT03121495 - Study on Second Forward View Examination in the Right Colon N/A
Completed NCT03344055 - Endocuff-assisted Colonoscopy vs Standard Colonoscopy on Adenoma Detection Rate N/A
Recruiting NCT06063720 - Effective Withdrawal Time and Adenoma Detection Rate
Recruiting NCT04220905 - Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study
Completed NCT04693078 - Detection of Colonic Polyps Via a Large Scale Artificial Intelligence (AI) System N/A
Completed NCT05242562 - Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life N/A